These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 39056800)

  • 1. Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet's Stripping Only Model.
    Parekh M; Miall A; Chou A; Buhl L; Deshpande N; Price MO; Price FW; Jurkunas UV
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
    Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
    Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
    Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
    Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
    Macsai MS; Shiloach M
    Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1.
    Pizzuto S; Duffey G; Weant J; Eveleth D
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descemet stripping only and ripasudil for the treatment of traumatic Descemet's membrane ruptures.
    Fernández López E; Montolío-Marzo S; Ortega Pérez C; Catalán Gómez M; Peris Martínez C; Piá Ludeña JV; Chan E
    Eur J Ophthalmol; 2023 Jul; 33(4):NP13-NP18. PubMed ID: 35435049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descemet's stripping without endothelial keratoplasty.
    Garcerant D; Hirnschall N; Toalster N; Zhu M; Wen L; Moloney G
    Curr Opin Ophthalmol; 2019 Jul; 30(4):275-285. PubMed ID: 31033737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
    Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous corneal clearing after Descemet's stripping without endothelial replacement.
    Shah RD; Randleman JB; Grossniklaus HE
    Ophthalmology; 2012 Feb; 119(2):256-60. PubMed ID: 21982414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rho-associated protein kinase activity enhances oxidative phosphorylation to support corneal endothelial cell migration.
    Ho WT; Chang JS; Chen TC; Wang JK; Chang SW; Yang MH; Jou TS; Wang IJ
    FASEB J; 2022 Jul; 36(7):e22397. PubMed ID: 35661268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of descemet's stripping without keratoplasty in management of endothelial disease.
    Northey LC; Moloney G
    Curr Opin Ophthalmol; 2023 Jul; 34(4):348-353. PubMed ID: 37254864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin lenticule Descemet's stripping automated endothelial keratoplasty: single, slow pass technique.
    Vajpayee RB; Maharana PK; Jain S; Sharma N; Jhanji V
    Clin Exp Ophthalmol; 2014 Jul; 42(5):411-6. PubMed ID: 24224697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
    Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
    Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descemet Stripping without Transplantation in Fuchs Endothelial Corneal Dystrophy.
    Menzel-Severing J; Geerling G
    Klin Monbl Augenheilkd; 2022 Jun; 239(6):760-766. PubMed ID: 35580623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Corneal Endothelial Cell Migration in Fuchs Endothelial Corneal Dystrophy: A Live Cell Imaging Study.
    Ong Tone S; Wylegala A; Böhm M; Melangath G; Deshpande N; Jurkunas UV
    Ophthalmol Sci; 2021 Mar; 1(1):100006. PubMed ID: 36246012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo excimer laser ablation of cornea guttata and ROCK inhibitor-aided endothelial recolonization of ablated central cornea.
    Kassumeh S; von Studnitz A; Priglinger SG; Fuchshofer R; Luft N; Moloney G; Dirisamer M; Ohlmann A
    Acta Ophthalmol; 2020 Sep; 98(6):e773-e780. PubMed ID: 32017400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture of human corneal endothelial cells isolated from corneas with Fuchs endothelial corneal dystrophy.
    Zaniolo K; Bostan C; Rochette Drouin O; Deschambeault A; Perron MC; Brunette I; Proulx S
    Exp Eye Res; 2012 Jan; 94(1):22-31. PubMed ID: 22134119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-Term Failure of Descemet's Stripping Only and Fuchs' Dystrophy With Pancorneal Guttae.
    Arsiwalla T; Trinh T; Goolam S; Benito-Pascual B; Devasahayam RN; Moloney G
    Cornea; 2022 Aug; 41(8):1064-1067. PubMed ID: 35830584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
    Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
    PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.